PharmiWeb.com - Global Pharma News & Resources
16-Jul-2020

Drägerwerk AG & Co. KGaA: Dräger will expand capacity for mask production and will set up production in the United Kingdom to deliver respiratory masks to British government

Drägerwerk AG & Co. KGaA / Key word(s): Incoming Orders
Drägerwerk AG & Co. KGaA: Dräger will expand capacity for mask production and will set up production in the United Kingdom to deliver respiratory masks to British government

16-Jul-2020 / 14:49 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Ad-hoc notification in accordance with Sec. 17 of the MAR

Drägerwerk AG & Co. KGaA: Dräger will expand capacity for mask production and will set up production in the United Kingdom to deliver respiratory masks to British government

In connection with the COVID 19 pandemic, Dräger has received an order from the British government to deliver respiratory masks (FFP3). The delivery of the order will start in 2020 and will stretch until end of 2021. The expected net sales are roughly one hundred million Euro. For this purpose Dräger will set up a mask production in the United Kingdom. This is in addition to the existing production network in Sweden and South Africa and the previously decided new production sites in France and the United States. The investment into the expansion across all five production sites in 2020 will be in the amount of a mid-double digit million Euro figure.

Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23558 Lübeck, Deutschland
www.draeger.com

Investor Relations:
Thomas Fischler
Tel. +49 451 882-2685
thomas.fischler@draeger.com

Corporate Communications:
Melanie Kamann
Tel. +49 451 882-3998
melanie.kamann@draeger.com

Disclaimer
This ad hoc report contains statements on the future development of Dräger Group. These forward-looking statements are based on the current expectations, presumptions, and forecasts of the Executive Board as well as the information available to date. They were compiled to the best of the company's knowledge. Dräger does not provide any warranty nor assume any responsibility for the future developments and results described above. These are dependent on a number of factors. They entail various risks and contingencies outside of the company's influence and are based on assumptions which could prove to be incorrect. Dräger does not assume any responsibility for updating the forward-looking statements contained in this report. This does not infringe any legal stipulations on the adjustment of forecasts. Please go to Investor Relations / Definitions of financial indicators at www.draeger.com for information on alternative performance measures used.


16-Jul-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23542 Lübeck
Germany
Phone: +49 (0)451 882-0
Fax: +49 (0)451 882-2080
E-mail: info@draeger.com
Internet: www.draeger.com
ISIN: DE0005550602, DE 000 555 063 6, DE 000 555 065 1, DE 000 555 067 7, DE 000 555 071 9
WKN: 555060, 555063 Vorzüge, 555065 Genussschein A, 555067 Genussschein K, 555071 Genussschein D
Indices: TecDAX
Listed: Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime Standard), Hamburg, Hanover, Munich; Regulated Unofficial Market in Stuttgart, Tradegate Exchange
EQS News ID: 1095559

 
End of Announcement DGAP News Service

Editor Details

Last Updated: 16-Jul-2020